
Recent study has found that drugs designed to prevent organ rejection in transplant patients may also protect against the development of Alzheimer's disease.
Researchers from The University of Texas Medical Branch at Galveston analyzed the medical records of 2,644 patients who received organ transplants — and were taking drugs to prevent rejection.
Advertisement
They found that these patients were far less likely to develop dementia than the general population. Only eight patients developed dementia — two younger than 65 years of age, five between 65 and 74, and just one over 75.
The findings, published in the Journal of Alzheimer's Disease, suggest that anti-organ-rejection medications taken by transplant patients that block an enzyme known as calcineurin, which regulates communication between brain cells, also prevent dementia.
"These data clearly show that the prevalence of dementia and Alzheimer's in our transplant patient group is significantly lower, in fact almost absent, when compared to national data from the general population," noted lead researcher Luca Cicalese.
Source: Medindia
"These data clearly show that the prevalence of dementia and Alzheimer's in our transplant patient group is significantly lower, in fact almost absent, when compared to national data from the general population," noted lead researcher Luca Cicalese.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.

Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.

Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.

In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.

Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.